Literature DB >> 12583997

Construction and evaluation of a plasmid vector for the expression of recombinant lipoproteins in Escherichia coli.

Paul A Cullen1, Miranda Lo, Dieter M Bulach, Stuart J Cordwell, Ben Adler.   

Abstract

Outer membrane lipoproteins are emerging as key targets for protective immunity to many bacterial pathogens. Heterologous expression of lipoproteins in Escherichia coli does not always result in high level expression of acylated recombinant protein. Thus, these proteins do not take up their correct membrane topology and are lacking the immunostimulatory properties endowed by the lipid. To this end, we have designed a lipoprotein expression vector (pDUMP) that results in the production of fusion proteins containing the E. coli major outer membrane lipoprotein (Lpp) signal sequence, lipoprotein signal peptidase recognition site, and the +2 outer membrane sorting signal at their N termini. To test the ability of pDUMP to express lipoproteins from heterologous hosts, the surface lipoprotein PsaA from the Gram-positive organism Streptococcus pneumoniae and the outer membrane lipoproteins MlpA from the Gram-negative Pasteurella multocida and BlpA from the spirochete Brachyspira hyodysenteriae were cloned into both hexahistidine fusion vectors and pDUMP. High level expression of antigenically active protein from both the hexahistidine fusion vectors and pDUMP resulted in abundant bands of the predicted molecular masses when analyzed by SDS-PAGE. When grown in the presence of 3[H]palmitic acid, proteins encoded by pDUMP were observed to incorporate palmitic acid whilst the hexahistidine fusion proteins did not. Using mass spectrometry and image analysis we determined the efficiency of lipidation between the three clones to vary from 31.7 to 100%. In addition, lipidated, but not hexahistidine, forms of the proteins were presented on the E. coli surface. Copyright 2002 Published by Elsevier Science (USA)

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12583997     DOI: 10.1016/s0147-619x(02)00150-6

Source DB:  PubMed          Journal:  Plasmid        ISSN: 0147-619X            Impact factor:   3.466


  12 in total

1.  Vaccine candidates PhtD and PhtE of Streptococcus pneumoniae are adhesins that elicit functional antibodies in humans.

Authors:  M Nadeem Khan; Michael E Pichichero
Journal:  Vaccine       Date:  2012-02-17       Impact factor: 3.641

2.  Human antibody response to outer membrane protein G1a, a lipoprotein of Moraxella catarrhalis.

Authors:  Diana G Adlowitz; Sanjay Sethi; Paul Cullen; Ben Adler; Timothy F Murphy
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

3.  Characterization and evaluation of the Moraxella catarrhalis oligopeptide permease A as a mucosal vaccine antigen.

Authors:  Min Yang; Antoinette Johnson; Timothy F Murphy
Journal:  Infect Immun       Date:  2010-12-06       Impact factor: 3.441

4.  The Vaccine Candidate Substrate Binding Protein SBP2 Plays a Key Role in Arginine Uptake, Which Is Required for Growth of Moraxella catarrhalis.

Authors:  Taketo Otsuka; Charmaine Kirkham; Aimee Brauer; Mary Koszelak-Rosenblum; Michael G Malkowski; Timothy F Murphy
Journal:  Infect Immun       Date:  2015-11-23       Impact factor: 3.441

5.  Characterization of proteins Msp22 and Msp75 as vaccine antigens of Moraxella catarrhalis.

Authors:  Elizabeth A Ruckdeschel; Aimee L Brauer; Antoinette Johnson; Timothy F Murphy
Journal:  Vaccine       Date:  2009-09-26       Impact factor: 3.641

6.  Mining the Moraxella catarrhalis genome: identification of potential vaccine antigens expressed during human infection.

Authors:  Elizabeth A Ruckdeschel; Charmaine Kirkham; Alan J Lesse; Zihua Hu; Timothy F Murphy
Journal:  Infect Immun       Date:  2008-01-28       Impact factor: 3.441

7.  Substrate binding protein SBP2 of a putative ABC transporter as a novel vaccine antigen of Moraxella catarrhalis.

Authors:  Taketo Otsuka; Charmaine Kirkham; Antoinette Johnson; Megan M Jones; Timothy F Murphy
Journal:  Infect Immun       Date:  2014-06-09       Impact factor: 3.441

Review 8.  Vaccine targets against Moraxella catarrhalis.

Authors:  Dabin Ren; Michael E Pichichero
Journal:  Expert Opin Ther Targets       Date:  2015-08-26       Impact factor: 6.902

9.  Breast-feeding is associated with a reduced frequency of acute otitis media and high serum antibody levels against NTHi and outer membrane protein vaccine antigen candidate P6.

Authors:  Albert Sabirov; Janet R Casey; Timothy F Murphy; Michael E Pichichero
Journal:  Pediatr Res       Date:  2009-11       Impact factor: 3.756

10.  Molecular characterization and subcellular localization of macrophage infectivity potentiator, a Chlamydia trachomatis lipoprotein.

Authors:  Laurence Neff; Sawsan Daher; Patrick Muzzin; Ursula Spenato; Fazil Gülaçar; Cem Gabay; Sylvette Bas
Journal:  J Bacteriol       Date:  2007-04-20       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.